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O B J E C T I V E . To determine rates of blood culture contamination comparing 3 strategies to prevent intensive care unit (ICU) infections: 
screening and isolation, targeted decolonization, and universal decolonization. 
D E S I G N . Pragmatic cluster-randomized trial. 
S E T T I N G . Forty-three hospitals with 74 ICUs; 42 of 43 were community hospitals. 
P A T I E N T S . Patients admitted to adult ICUs from July 1, 2009, to September 30, 2011. 
M E T H O D S . After a 6-month baseline period, hospitals were randomly assigned to 1 of 3 strategies, with all participating adult ICUs in 
a given hospital assigned to the same strategy. Arm 1 implemented methicillin-resistant Staphylococcus aureus (MRSA) nares screening and 
isolation, arm 2 targeted decolonization (screening, isolation, and decolonization of MRSA carriers), and arm 3 conducted no screening 
but universal decolonization of all patients with mupirocin and chlorhexidine (CHG) bathing. Blood culture contamination rates in the 
intervention period were compared to the baseline period across all 3 arms. 
RESULTS. During the 6-month baseline period, 7,926 blood cultures were collected from 3,399 unique patients: 1,099 sets in arm 1, 928 
in arm 2, and 1,372 in arm 3. During the 18-month intervention period, 22,761 blood cultures were collected from 9,878 unique patients: 
3,055 sets in arm 1, 3,213 in arm 2, and 3,610 in arm 3. Among all individual draws, for arms 1, 2, and 3, the contamination rates were 
4.1%, 3.9%, and 3.8% for the baseline period and 3.3%, 3.2%, and 2.4% for the intervention period, respectively. When we evaluated sets 
of blood cultures rather than individual draws, the contamination rate in arm 1 (screening and isolation) was 9.8% (JV = 108 sets) in the 
baseline period and 7.5% (N = 228) in the intervention period. For arm 2 (targeted decolonization), the baseline rate was 8.4% (JV = 
78) compared to 7.5% (JV = 241) in the intervention period. Arm 3 (universal decolonization) had the greatest decrease in contamination 
rate, with a decrease from 8.7% (JV = 119) contaminated blood cultures during the baseline period to 5.1% (JV = 184) during the 
intervention period. Logistic regression models demonstrated a significant difference across the arms when comparing the reduction in 
contamination between baseline and intervention periods in both unadjusted (P = .02) and adjusted (P = .02) analyses. Arm 3 resulted 
in the greatest reduction in blood culture contamination rates, with an unadjusted odds ratio (OR) of 0.56 (95% confidence interval [CI], 
0.044-0.71) and an adjusted OR of 0.55 (95% CI, 0.43-0.71). 
C O N C L U S I O N . In this large cluster-randomized trial, we demonstrated that universal decolonization with CHG bathing resulted in a 
significant reduction in blood culture contamination. 
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American Pathologists' benchmark for contaminated blood 
cultures hospital wide is between 2.5% and 3%.4,5 In recent 
studies the overall blood culture contamination rate in in-
tensive care unit (ICU) populations ranged from 4% to 
5.5%.6'7 "Contamination" in these reports is defined as the 
number of contaminated blood cultures divided by the total 
number of blood culture draws multiplied by 100. Contam-
ination can lead to unnecessary antimicrobial therapy, un-
necessary removal of central lines, unnecessary testing, in-
creased length of stay, and increased cost. Bates et al8 
estimated the cost of contaminated blood cultures at $4,500 
per episode. Patients with contaminated blood cultures are 
just as likely to receive antimicrobial therapy as patients with 
true bacteremia.9 It has been reported that up to half of 
patients with false-positive blood cultures for coagulase-neg-
ative staphylococci were treated with antibiotics, usually van-
comycin, with an estimated additional cost of approximately 
$1,000 per patient.10 This association between contaminated 
blood cultures and unnecessary antibiotic use, additional lab-
oratory tests, and increased hospital length of stay and excess 
costs has been confirmed in subsequent studies, with costs 
as high as $10,000.1112 
Contamination of percutaneous blood cultures is thought 
to be due to the introduction of organisms from the skin of 
the patient into the collected sample.13 Inadequate prepara-
tion of the skin is thought to be the most common cause of 
blood culture contamination.14 This is supported by surveys 
of the most common organisms in contaminated blood cul-
tures, which represent organisms that are known to be present 
on the skin of hospitalized patients. The most common con-
taminant is coagulase-negative staphylococci, which accounts 
for approximately 75% of contaminated blood cultures, fol-
lowed by Propionibacterium sp., Micrococcus sp., Corynebac-
terium sp., Bacillus sp. (not Bacillus anthracis), Micrococcus 
sp., viridans streptococci, and 7-hemolytic streptococci (not 
Enterococcus sp.).4'9'15 Accordingly, interventions that have 
been studied to reduce contamination are those that could 
reduce skin bacterial load or reduce the likelihood of inad-
vertent introduction of skin contaminants into the sample. 
These include disinfection methods for skin preparation, cul-
ture bottle preparation, needle exchange for bottle inocula-
tion, limiting the use of blood drawn from intravenous lines, 
and the use of dedicated phlebotomy teams.4 Recently, several 
studies have suggested that chlorhexidine (CHG) bathing of 
patients in the ICU may reduce blood culture contamination 
rates.1618 
In our previous publication,19 we reported that universal 
decolonization was more effective than targeted decoloniza-
tion or screening and isolation in reducing methicillin-resis-
tant Staphylococcus aureus (MRSA) clinical cultures and 
bloodstream infections from any pathogen. In this study, we 
investigated whether these 3 strategies to prevent ICU infec-
tions would have an effect on the rates of blood culture 
contamination. 
M E T H O D S 
Study Design 
The Randomized Evaluation of Decolonization vs Universal 
Clearance to Eradicate MRSA (REDUCE MRSA) trial was a 
3-arm cluster-randomized trial of hospitals in the Hospital 
Corporation of America (HCA) system. This study compared 
3 strategies to decrease MRSA infections in adult ICUs. El-
ements of the trial design have been previously described.17 
The strategies were limited to the adult ICU and included: 
• Arm 1: Screening and isolation: Patients received bilateral 
nares screening for MRSA upon ICU admission. Contact 
precautions were employed for patients with a known his-
tory of MRSA (either colonization or infection) or a current 
culture or screening test positive for MRSA. This arm was 
considered standard of care at the time and in practice since 
2007.18 
• Arm 2: Targeted decolonization: At ICU admission, patients 
received MRSA screening and contact precautions similar 
to arm 1. Patients with known MRSA colonization received 
decolonization with twice daily intranasal 2% mupirocin 
ointment and daily 2% CHG cloth baths for 5 days. 
• Arm 3: Universal decolonization: There was no screening 
for MRSA at ICU admission. Contact precautions similar 
to arm 1 were employed. All ICU patients received twice 
daily intranasal mupirocin ointment for 5 days plus daily 
2% CHG cloth baths for the entire duration of their ICU 
stay. 
This study consisted of a 6-month baseline period from 
July 1 to December 31, 2009; a phase-in period from January 
1 to April 7, 2010; and an 18-month intervention period from 
April 8, 2010, to September 30, 2011. This study was approved 
by the Harvard Pilgrim Health Care institutional review 
board. 
Determination of Blood Culture Contamination 
For descriptive purposes, we provide the percent of all blood 
culture draws either by a percutaneous (direct skin puncture) 
or from an existing intravascular catheter that contained a 
skin commensal consistent with contamination. The perfor-
mance of an individual blood culture commonly involves 
collecting a volume of blood either via venipuncture or from 
an intravascular catheter and distributing it into 1 or more 
bottles (eg, an aerobic and anaerobic bottle). However, in 
keeping with clinical application, all analyses were performed 
at the level of blood culture sets unless otherwise specified. 
Blood culture sets were eligible for the determination of con-
tamination if at least 2 ICU-attributed blood cultures were 
drawn within 2 calendar days of one another. Thus, a single 
blood culture draw within a 2-day period was excluded from 
evaluation. Two or more blood cultures during that time 
window constituted a single set. Only the first eligible set per 
patient was evaluated. Blood cultures were deemed attrib-
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TABLE 1. Patient Characteristics by Strategies to Reduce Blood Culture Contamination in Intensive Care Units 
Variable 
Admissions with ICU stay and 
blood draw set 
Draws per patient, median (IQR) 
Length of hospital stay, days, 
median (IQR) 
Length of ICU stay, days, me-
dian (IQR) 
Age, years, median (IQR) 
Female 
Race 
White 
Black 
Hispanic 
Asian 
Other 
Unknown 
Insurance 
Medicare 
Commercial 
Medicaid 
Self-pay 
Free care 
Other 
Unknown 
Comorbidities 
COPD 
Diabetes 
Congestive heart failure 
Renal failure 
Myocardial infarction 
Cerebrovascular disease 
Peripheral vascular disease 
Cancer 
Hemiplegia/paraplegia 
Liver failure 
Peptic ulcer disease 
Rheumatologic disease 
Dementia 
AIDS 
Surgery during admission 
Baseline, 6 months, 
Arm 1 
1,099 
2 ( 0 ) 
15 (15) 
8(11) 
64 (23) 
43.1 
73.0 
14.9 
4.6 
2.7 
2.3 
2.5 
56.1 
23.0 
11.0 
5.9 
2.1 
1.8 
0.0 
29.7 
29.8 
30.5 
22.9 
83.7 
15.6 
9.3 
10.3 
6.6 
6.8 
4.0 
1.7 
1.7 
0.7 
42.9 
Arm 2 
928 
2 ( 0 ) 
14 (15.5) 
8(10) 
65 (22) 
44.3 
75.1 
12.8 
8.5 
1.0 
1.3 
1.3 
60.3 
19.4 
13.1 
4.3 
2.3 
0.5 
0.0 
30.4 
32.8 
34.4 
25.4 
81.3 
17.7 
10.1 
11.1 
7.0 
9.2 
4.5 
3.0 
1.7 
0.5 
42.1 
N = 3,399 
Arm 3 
1,372 
2 ( 0 ) 
15 (16) 
8(11) 
63 (26) 
45.6 
67.1 
10.6 
16.9 
1.1 
2.5 
1.9 
56.9 
19.3 
13.7 
5.2 
2.8 
1.5 
0.5 
28.1 
30.1 
28.1 
24.1 
83.7 
17.6 
10.6 
10.2 
7.0 
6.0 
3.4 
3.1 
2.6 
0.9 
48.3 
P 
.6 
.6 
.2 
.5 
.6 
1.0 
1.0 
.9 
.7 
.4 
.8 
.5 
.7 
.5 
.8 
.9 
1.0 
.7 
.1 
.3 
.8 
.9 
Intervention, 18 months, N = 9,878 
Arm 1 
3,055 
2 ( 0 ) 
14(13) 
8 (10) 
64 (23) 
42.3 
73.9 
14.6 
4.7 
2.7 
2.5 
1.6 
58.1 
20.7 
10.7 
6.3 
1.5 
2.6 
0.1 
31.3 
30.4 
30.7 
25.0 
83.5 
17.0 
8.6 
9.2 
6.8 
4.1 
3.4 
2.2 
2.3 
1.4 
40.0 
Arm 2 
3,213 
2 ( 0 ) 
14 (14) 
8 (10) 
65 (24) 
45.3 
74.5 
12.9 
8.9 
1.1 
1.0 
1.6 
60.9 
18.1 
11.0 
6.5 
2.0 
1.3 
0.1 
30.9 
32.1 
31.8 
26.8 
83.1 
14.3 
10.1 
10.4 
6.1 
4.7 
3.4 
2.6 
2.3 
0.7 
41.4 
Arm 3 
3,610 
2 ( 0 ) 
14 (14) 
8(10) 
63 (24) 
44.5 
66.9 
10.0 
18.8 
0.6 
2.4 
1.3 
57.1 
18.9 
11.5 
6.4 
3.4 
2.2 
0.5 
29.0 
29.9 
29.2 
24.4 
83.4 
18.0 
11.0 
11.7 
7.1 
3.6 
3.3 
3.5 
2.5 
0.8 
47.2 
P 
.5 
.9 
1.0 
.5 
.4 
1.0 
1.0 
.9 
.6 
.9 
.8 
1.0 
.3 
.1 
.3 
.9 
.4 
1.0 
.03 
.6 
.03 
.5 
NOTE. All data shown are percentages, unless otherwise indicated. COPD, chronic obstructive pulmonary disease; ICU, intensive 
care unit; IQR, interquartile range. 
utable to the ICU if the draws occurred more than 1 day into 
the ICU stay through the day of ICU discharge. This attri-
bution window was selected to allow for the first CHG bath 
to be given in the ICU. We were unable to determine ac-
curately which blood cultures were drawn by venipuncture 
or from an existing line. 
Among eligible blood culture sets, contamination was de-
fined as having 1 or more of the following pathogens isolated 
from only 1 blood culture within the set: coagulase-negative 
Staphylococcus sp., Lactobacillus sp., Propionibacterium acnes, 
Corynebacterium sp., Bacillus sp. (not B. anthracis), Micro-
coccus sp., viridans streptococci, and 7-hemolytic streptococci 
(not Enterococcus sp.). Our analysis focuses on the proportion 
of eligible blood culture sets that had a contamination event 
across all 3 study arms. 
Statistical Analysis 
Census and microbiologic information were obtained from 
the HCA centralized clinical electronic data warehouse. The 
HCA system uses a single electronic health record (EHR) 
platform including the microbiology module for test orders 
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Results from Logistic Regression Models for Blood Culture Contamination 
Arm 1 Arm 2 Arm 3 
OR (95% CI) OR (95% CI) OR (95% CI) 
Overall trial 
As randomized, unadjusted 
As randomized, adjusted by no. of draws 
As randomized, adjusted by no. of draws, age, 
sex, race, payer, surgery, and comorbidities 
As treated, unadjusted 
Randomization to all 3 arms, unadjusted 
Accounting for randomization strata, unadjusted 
Weekday draws (entire set collected on weekday) 
Weekend draws (any in set collected on weekend) 
Day draws (entire set collected 5 am-4:49 pm) 
Night draws (any in set collected 5 pm-4:59 am) 
0.74 (0.58-0.94) 0.94 (0.72-1.23) 0.56 (0.44-0.71) 
0.74 (0.58-0.95) 0.93 (0.71-1.23) 0.56 (0.44-0.71) 
0.73 (0.57-0.94) 
0.74 (0.58-0.94) 
0.75 (0.58-0.96) 
0.73 (0.58-0.94) 
0.77 (0.57-1.05) 
0.66 (0.44-0.99) 
0.71 (0.5-1.02) 
0.79 (0.56-1.11) 
0.93 (0.7-1.22) 
0.93 (0.71-1.22) 
0.9 (0.68-1.19) 
0.94 (0.72-1.23) 
0.82 (0.6-1.13) 
1.2 (0.72-1.98) 
0.97 (0.68-1.39) 
0.9 (0.59-1.37) 
0.55 (0.43-0.71) 
0.56 (0.44-0.71) 
0.56 (0.44-0.71) 
0.56 (0.44-0.71) 
0.56 (0.41-0.76) 
0.56 (0.39-0.83) 
0.64 (0.46-0.9) 
0.44 (0.31-0.62) 
.02 
.02 
.02 
.02 
.03 
.02 
.18 
.06 
.24 
.01 
NOTE. P values in the pairwise analysis were as follows: P = .19 for the comparison of arm 2 with arm 1; P = .11 for the 
comparison of arm 3 with arm 1; and P = .005 for the comparison of arm 3 with arm 2. 
and resulting. The contamination rate was calculated as a 
percentage of eligible blood culture sets. 
We used generalized linear mixed models to account for 
the cluster-randomized design of the trial. In that context, 
we used logistic regression to assess the treatment arm, period, 
and arm-by-period interaction effect. The 2-degree-of-free-
dom test assessing the interaction addresses the null hypoth-
esis that the change from baseline to intervention period was 
the same in each arm. Sensitivity analysis included multi-
variable covariate-adjusted models that accounted for age, 
sex, race, insurance type, coexisting conditions, and surgery 
during the hospital stay. Analyses were performed with use 
of Statistical Analysis System (SAS) software, version 9.3 (SAS 
Institute). 
RESULTS 
Patient characteristics were similar across all groups and be-
tween baseline and intervention periods (Table 1). During 
the 6-month baseline period, 7,926 blood cultures were col-
lected from 3,399 unique patients: 1,099 sets in arm 1, 928 
in arm 2, and 1,372 in arm 3. During the 18-month inter-
vention period, 22,761 blood cultures were collected from 
9,878 unique patients: 3,055 sets in arm 1, 3,213 in arm 2, 
and 3,610 in arm 3. Among all individual draws, for arms 1, 
2, and 3, the contamination rates were 4.1%, 3.9%, and 3.8% 
for the baseline period and 3.3%, 3.2%, and 2.4% for the 
intervention period, respectively. 
When we evaluated sets of blood cultures rather than in-
dividual draws, the contamination rate in arm 1 (screening 
and isolation) was 9.8% (N = 108 sets) in the baseline period 
and 7.5% (N = 228) in the intervention period. For arm 2 
(targeted decolonization), the baseline rate was 8.4% (N = 
78) compared to 7.5% (N = 241) in the intervention period. 
Arm 3 (universal decolonization) had the greatest decrease 
in contamination rate, with a decrease from 8.7% (N = 119) 
contaminated blood cultures during the baseline period to 
5.1% (N = 184) during the intervention period. 
Logistic regression models for contaminated sets (Table 2) 
demonstrated a significant difference across the arms when 
comparing the reduction in contamination between baseline 
and intervention periods in both unadjusted (P = .02) and 
adjusted (P — .02) analyses. All arms showed a reduction in 
contamination between the intervention period and the base-
line period, but universal decolonization resulted in the 
greatest reduction in blood culture contamination rates, with 
an unadjusted odds ratio (OR) of 0.56 (95% confidence in-
terval [CI], 0.044-0.71) and an adjusted OR of 0.55 (95% 
CI, 0.43-0.71). P values in the pairwise analysis were as fol-
lows: P — .19 for the comparison of arm 2 with arm 1, P — 
.11 for the comparison of arm 3 with arm 1, and P = .005 
for the comparison of arm 3 with arm 2. Based on the ORs, 
universal decolonization avoided an additional 26.8 contam-
inated blood culture sets per 1,000 admissions compared to 
arm 2 and an additional 12.2 contaminated blood culture 
sets per 1,000 admissions compared to arm 1. The most com-
mon organism associated with contamination was coagulase-
negative Staphylococcus sp. (85.0%), followed by Streptococcus 
sp. (6.4%) and Bacillus sp. (3.0%; Table 3). 
D I S C U S S I O N 
Contamination of blood cultures can alter the course of a 
patient's treatment, resulting in outcomes such as inappro-
priate antibiotic use, longer hospital stays, or increased cost. 
Evidence suggests that the rate of blood culture contamina-
tion could potentially be influenced by interventions that 
decrease skin bacterial load, such as CHG bathing. 
Bleasdale et al16 examined the effectiveness of CHG bathing 
to reduce central line-associated bloodstream infections 
(CLABSIs) in a 2-ICU crossover study. They reported a sig-
nificant reduction in primary BSIs and a nonsignificant re-
duction in the incidence of blood culture contamination from 
4.3 to 1.8 per 1,000 patient-days. Popovich et al17'18 have 
reported significant declines in blood culture contamination 
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TABLE 3. Blood Culture Contamination Pathogens by Genus Group 
Baseline Intervention 
Arm 1 
0 
5 (3.1) 
2 (1.2) 
3 (1.9) 
0 
1 (0.6) 
0 
0 
2 (1.2) 
136 (84) 
13 (8) 
162 
Arm 2 
0 
4 (3.6) 
3 (2.7) 
0 
0 
0 
0 
0 
0 
93 (83) 
12 (10.7) 
112 
Arm 3 
0 
6 (4.1) 
3 (2.1) 
1 (0.7) 
0 
2 (1.4) 
1 (0.7) 
2 (1.4) 
0 
128 (88.3) 
2 (1.4) 
145 
Arm 1 
1 (0.3) 
9 (2.7) 
8 (2.4) 
5 (1.5) 
0 
4(1.2) 
2 (0.6) 
3 (0.9) 
1 (0.3) 
274 (83.3) 
22 (6.7) 
329 
Arm 2 
0 
8 (2.3) 
9 (2.6) 
2 (0.6) 
1 (0.3) 
3 (0.9) 
0 
4 (1.2) 
0 
293 (85.7) 
22 (6.4) 
342 
Arm 3 
0 
8 (3.5) 
5 (2.2) 
0 
1 (0.4) 
3 (1.3) 
2 (0.9) 
0 
0 
196 (86) 
13 (5.7) 
228 
Total 
1 (0.1) 
40(3) 
30 (2.3) 
11 (0.8) 
2 (0.2) 
13(1) 
5 (0.4) 
9 (0.7) 
3 (0.2) 
1,120 (85) 
84 (6.4) 
1,318 
Aerococcus sp. 
Bacillus sp. (not anthracis) 
Corynebacterium sp. 
Diphtheroids 
Lactobacillus sp. 
Micrococus sp. 
Peptostreptococcus sp. 
Propionibacterium sp. 
Saccharomyces sp. 
Staphylococcus, coagulase-
negative species 
Streptococcus sp." 
Total pathogens 
NOTE. All data are no. (%). Multiple pathogens per specimen were allowed. 
a
 Viridans group and gamma hemolytic Streptococcus, not Enterococcus sp. 
rates in both medical ICUs (6.99 to 4.1 per 1,000 patient-
days) and surgical ICUs (5.97 to 2.41 per 1,000 patient-days). 
In this large cluster-randomized trial, we demonstrated that 
universal decolonization with CHG bathing resulted in a sig-
nificant reduction in blood culture contamination. Of interest 
the 45% reduction in blood culture contamination with uni-
versal decolonization is virtually identical to the 44% reduc-
tion of all cause bloodstream infections previously reported.19 
In this study, we observed a decrease in blood culture 
contamination in all arms of the study, suggesting a secular 
trend despite the comprehensive efforts to prevent competing 
interventions during the trial.19 While we inquired monthly 
about competing interventions and participating hospitals 
were instructed to bring any product or practice changes 
before the study steering committee, it is possible that na-
tional attention to skin or line connector preparation prior 
to phlebotomy, national efforts to support drawing blood by 
venipuncture whenever possible, and the concept of dedicated 
phlebotomy teams may have had a secular impact. 
Almost all HCA facilities track blood culture contamina-
tion rates as a quality indicator, with appropriate action taken 
when rates are determined to be greater than 3% after blood 
culture draws. This included reeducation along retraining 
healthcare professionals' skills on specimen collection and 
limiting use of blood draws from intravenous lines. Also, to 
address national guidance for best practice, HCA launched a 
campaign as part of a patient safety initiative to reduce 
CLABSIs, emphasizing maintenance of lines including 
"scrubbing the hub" and standardizing connectors to meet 
certain design and safety criteria, making it easier to ade-
quately disinfect the hub. This initiative was equally applied 
across all 3 arms. This initiative, along with tracking contam-
ination rates, probably explains the secular trend noted in 
this analysis. 
We believe that the benefit attributable to universal de-
colonization (arm 3) relates to reducing patient bioburden 
by reducing skin colonization20 since inadequate skin prep-
aration is thought to be the most common cause of blood 
culture contamination.413 In addition, our protocol included 
not only cleaning of the skin with 2% CHG cloths but also 
wiping of the proximal 6 inches of the line, including the 
connectors and hubs, with 2% CHG cloths. Coagulase-neg-
ative Staphylococcus sp. was the most common contaminant 
in our trial, consistent with other publications.4,915 
The strength of our study was the large size and rigorous 
design as a pragmatic comparative effectiveness trial imple-
mented primarily through the hospital processes. This design 
was chosen so that the implementation could be generalized 
to the broadest set of hospitals with available resources. Our 
study, however, had several limitations. Since microbiologic 
data were captured through our early clinical data warehouse, 
we were not then able to capture clinical signs or symptoms 
that could be associated with a clinical infection. In addition 
we were unable to account for the method of blood draw, 
including the method of skin cleaning and whether blood 
cultures were taken peripherally or from an existing line. 
However, such differences across groups are largely accounted 
for by comparing the outcome rate in each hospital with that 
hospital's baseline rate, providing reassurance that the benefit 
is attributable to decolonization rather than to baseline var-
iation in case-mix or clinical practices across groups. 
In conclusion, our study, along with other studies, clearly 
demonstrated that CHG bathing has a role in decreasing 
blood culture contamination rates. As this study showed, in-
terventions targeted at different outcomes, such as the re-
duction of bloodstream infections, can also drive improve-
ments in the rate of blood culture contaminations. Reduction 
of blood culture contamination can improve the quality of 
blood culture results and can prevent unnecessary antibiotics, 
decrease cost, and decrease length of stay. 
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